Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study
Published Online: 2023-05-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Chen-Yuan Lin•Eric Raymond•Eric Van Cutsem•Evgeny Gotovkin•Harry H Yoon•Jianming Xu•Jingdong Zhang•Jingwen Shi•Ken Kato•Lei Wang•Lin Shen•Liyun Li•Lu Ping•Lucjan Wyrwicz•Paula Jimenez-Fonseca•Richard A Hubner•Ryu Ishihara•Sook Ryun Park•Takashi Kojima•Xiaohong Wu•Yi Jiang•Yongqian Shu•Yuanhu Yao•Yueyin Pan
